Effect of Treatment Modality on Long-Term Outcomes in Attention-Deficit/Hyperactivity Disorder: A Systematic Review
Fig 3. Treatment Modalities.
(A) Benefit with each treatment modality for each outcome domain. Each bar represents the percentage of outcomes reported to exhibit benefit (either significantly improved from untreated baseline or significantly improved compared with a group of untreated individuals with ADHD) with each treatment modality. (B) Benefit with each treatment modality for different age groups at follow-up. The colored sections within bars represent the percentage of outcomes reported to improve (benefit) or not (no benefit) for each treatment modality for children (mid-range age 6–12 years) and adolescents (mid-range age 13–17 years), and all ages. Adults (mid-range age 18–84 years) are not presented separately because there were only studies of pharmacological treatment in this age group at follow-up. The numbers on the bars indicate the number of outcomes represented in each bar. Some studies reported outcomes with more than one type of treatment.